PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This is a proof-of-concept study to determine if PH-797804 reduces neuropathic pain associated with post-herpetic neuralgia. Suitable patients will be randomized to receive either PH-797804 or placebo for 4 weeks, during which time they will also record their pain symptoms using various pain scales.
Epistemonikos ID: e34e21f7c87a41c61038e89bb6df5168f467dccf
First added on: May 04, 2024